Here we report IHC staining of ERα, PR, AR and HER2 complemented with HER2 in situ hybridization in 69 patients with primary breast carcinomas and their matched malignant peritoneal and/or pleural effusions and solid distant metastases. This evidence concerns the gene ERBB2 and breast carcinoma.